RUNX2 prompts triple negative breast cancer drug resistance through TGF-β pathway regulating breast cancer stem cells.
Journal Information
Full Title: Neoplasia
Abbreviation: Neoplasia
Country: Unknown
Publisher: Unknown
Language: N/A
Publication Details
Related Papers from Same Journal
Transparency Score
3/6
50.0% Transparent
Transparency Indicators
Click on green indicators to view evidence textCore Indicators
Data Sharing
Code Sharing
COI Disclosure
Evidence found in paper:
"Declaration of competing interest The authors declare that they have no competing interests."
Funding Disclosure
Evidence found in paper:
"Funding This work was supported by the 10.13039/501100001809National Natural Science Foundation of China (Nos. 82173377, 81302319), the Major Research Project of Education Department of Anhui Province (KJ2018ZD018)."
Protocol Registration
Open Access
Paper is freely available to read
Additional Indicators
Replication
Novelty Statement
Assessment Info
Tool: rtransparent
OST Version: N/A
Last Updated: Aug 05, 2025